Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
UNIVERSITAT HEIDELBERG has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 3 examiners and 3 art units, creating three distinct examination paths.
ALEMAN, SARAH WEBB is the busiest examiner, with 1 pending matter. No examiner has a larger reported workload, so effective prosecution management depends on matter-specific analysis and coordinated handling of the separate assignments.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALEMAN, SARAH WEBB | 1 | 62.2% | +23.6% |
| SHOMER, ISAAC | 1 | 63.1% | +30.5% |
| HILL, MYRON G | 1 | 66.1% | +20.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17924258 | COMPOSITION OF NANOPARTICLES | SHOMER, ISAAC | 52d overdue |
| 17924193 | COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED IMMUNOGENIC FRAGMENTS | HILL, MYRON G | 17d overdue |
| 18682257 | Endograft Device For Treating Ruptures In A Blood Vessel | ALEMAN, SARAH WEBB | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17924258 | COMPOSITION OF NANOPARTICLES | SHOMER, ISAAC | 52d overdue |
| 17924193 | COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED IMMUNOGENIC FRAGMENTS | HILL, MYRON G | 17d overdue |
| 18682257 | Endograft Device For Treating Ruptures In A Blood Vessel | ALEMAN, SARAH WEBB | — |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| 1612 | 1 |
| 1671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18682257 | Endograft Device For Treating Ruptures In A Blood Vessel | ALEMAN, SARAH WEBB | 3774 | §102§103§112 | Non-Final OA | — | Pending | Feb 08, 2024 |
| 17924258 | COMPOSITION OF NANOPARTICLES | SHOMER, ISAAC | 1612 | §102§103§112Other | Non-Final OA | 52d overdue | Pending | Nov 09, 2022 |
| 17924193 | COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED IMMUNOGENIC FRAGMENTS | HILL, MYRON G | 1671 | §103§112Other | Final Rejection | 17d overdue | Pending | Nov 09, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITAT HEIDELBERG has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Sarah Webb Aleman has the most, with 1 of UNIVERSITAT HEIDELBERG's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
